Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis

Acta Dermato-Venereologica

Volumn 79, Issue 1, 1999, Pages 9-11

  Raychaudhuri, Siba P ^a   Jiang, Wen Yue ^a   Farber, Eugene M ^a   Schall, Thomas J ^b   Ruff, Michael R ^c   Pert, Candace B ^c  

^a Psoriasis Research Institute   (United States)

^b ChemoCentryx Inc   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chemokine; Chemotaxis; Cutaneous inflammation

Indexed keywords

BETA CHEMOKINE; INTERLEUKIN 8; RANTES;

ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; ECZEMA; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; KERATINOCYTE; LICHEN PLANUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PSORIASIS; SKIN BIOPSY;

BIOPSY; CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; PSORIASIS; RANTES; SKIN; UP-REGULATION;

EID: 0033033801     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750011615     Document Type: Article

References (17)

1. 1. Schroder J, Christophers E. Identification of C5a des arg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986; 87: 53-58.
2. 2. Schroder J, Gregory H, Young J, et al. Neutrophil-activating proteins in psoriasis. J Invest Dermatol 1992; 98; 241-247.
3. 3. Kulke R, Todt-Pingel I, Rademacher D, Rowert J, Schroder J, Christophers E. Co-localized overexpression of GRO-α and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 1996; 106: 526-530.
4. 4. Deleuran M, Buhl L, Ellingsen T, et al. Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis. J Dermatol Sci 1996; 13: 228-236.
5. 5. Smowden N, Hajeer A, Thomson W, et al. RANTES role in rheumatoid arthritis. Lancet 1994; 343: 547-548.
6. 6. Deveregne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994; 179: 1689-1694.
7. 7. Pattison JM, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell mediated transplant rejection of the kidney. Lancet 1994; 343: 209-211.
8. 8. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3: 165-183.
9. 9. Pattison JM, Nelson PJ, Krensky AM. The RANTES chemokine: a new target for immunomodulatory therapy? Clin Immunother 1995; 4: 1-8.
10. 10. Li J, Ireland GW, Farthing PM, Thornhill MH. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996; 106: 661-666.
11. 11. Rathanaswami P, Hachicha M, Sadick M, et al. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J Biol Chem 1993; 268: 5834-5839.
12. 12. Baggiolini M, Dewald B, Moser B. Intedeukin-8 and related chemotactic cytokines - C × C and C-C chemokines. Adv Immunol 1994; 55: 97-179.
13. 13. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
14. 14. Leonard EJ, Yoshimura T, Tanka S, Raffeld M. Neutrophil recruitment by intradermally neutrophil attractant/activation protein-1. J Invest Dermatol 1991; 96: 690-694.
15. 15. Braun-Falco O. The initial psoriatic skin. In: Farber EM, Cox AJ, eds. Psoriasis. Proceedings of the 2nd International Symposium. Stanford: Stanford University Press.
16. 16. Heng MCY, Kloss SG. Cell interaction in psoriasis. Arch Dermatol 1985; 121: 881-887.
17. 17. Nikaein A, Morris L, Phillips C, et al. Characterization of T-cell clones generated from skin of patients with psoriasis. J Am Acad Dermatol 1993; 128: 493-499.